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Sharona Hoffman

The ever-growing phenomenon of predictive health analytics is
generating significant excitement, hope for improved health
outcomes, and potential for new revenues. Researchers are
developing algorithms to predict suicide, heart disease, stroke,
diabetes, cognitive decline, future opioid abuse, and other ailments.
The researchers include not only medical experts, but also
commercial enterprises such as Facebook and LexisNexis, who may
profit from the work considerably. This Article focuses on long-term
disease predictions (predictions regarding future illnesses), which
have received surprisingly little attention in the legal and ethical
literature. It compares the robust academic and policy debates and
legal interventions that followed the emergence of genetic testing to
the relatively anemic reaction to predictions produced by artificial
intelligence and other predictive methods. The paper argues that
like genetic testing, predictive health analytics raise significant
concerns about psychological harm, privacy breaches,
discrimination, and the meaning and accuracy of predictions.
Consequently, as alluring as the new predictive technologies are,
they require careful consideration and thoughtful safeguards.
These include changes to the HIPAA Privacy and Security Rules and
the Americans with Disabilities Act, careful oversight mechanisms,
and self-regulation by health care providers. Ignoring the hazards
of long-term predictive health analytics and failing to provide data
subjects with appropriate rights and protections would be a grave
mistake.



Edgar A. Hahn Professor of Law and Professor of Bioethics, Co-Director of
Law-Medicine Center, Case Western Reserve University School of Law; B.A.,
Wellesley College; J.D., Harvard Law School; LL.M. in Health Law, University
of Houston; S.J.D. in Health Law, Case Western Reserve University. Author of
Electronic Health Records and Medical Big Data: Law and Policy (Cambridge
University Press 2016). A huge thank you to Computer Science Professor Andy
Podgurski for everything he taught me about predictive health analytics and for
his astute comments on prior drafts. I also thank Melissa Vogley for her skillful
research assistance.
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I.

INTRODUCTION

The ever-growing phenomenon of predictive health
analytics is generating significant excitement, hope for improved
health outcomes, and potential for new revenues.1 Researchers are
developing algorithms to predict suicide, heart disease, stroke,
diabetes, cognitive decline, future opioid abuse, and other ailments.2
In 2017 the Society of Actuaries found that ninety-three percent of
health care and health insurance executives that it surveyed believed
that predictive analytics is important to their future success.3 Indeed,
experts forecast that predictive health analytics will be a
commonplace medical tool in the near future.4
Health care providers can use predictive health analytics for
treatment purposes in the short term.5 For example, predictive
health analytics can help physicians identify patients who are at risk
for hospital re-admission because of complications.6 This Article
focuses, however, on health analytics that predict health problems
in the more distant future, which I call “long-term predictive health
analytics.” For instance, scientists are developing techniques to
forecast conditions such as heart disease or cognitive decline that
are years or decades away.7
In some instances, such forecasts can be medically beneficial
because clinicians can commence early screening of affected
individuals and implement preventive interventions.8 In the case of

1

Jennifer Bresnick, 10 High-Value Use Cases for Predictive Analytics in
IT
ANALYTICS
(Sept.
4,
2018),
Healthcare,
HEALTH
https://healthitanalytics.com/news/10-high-value-use-cases-for-predictiveanalytics-in-healthcare.
2
See infra Parts II.B & C.
3
Society of Actuaries, Predictive Analytics in Healthcare Trend Forecast 2, 4
(2017),
https://www.soa.org/Files/programs/predictive-analytics/2017-healthcare-trend.pdf. The survey included 223 participants. Id. at 2.
4
Eric J. Topol, High-Performance Medicine: the Convergence of Human and
Artificial Intelligence, 25 NATURE MED. 44, (2019).
5
I. Glenn Cohen et al., The Legal and Ethical Concerns that Arise from Using
Complex Predictive Analytics in Healthcare, 33 HEALTH AFF. 1139, 1140 (2014)
(explaining that “it has become possible to apply predictive analytics to health
care”).
6
Id.
7
See infra Parts II.B. & C.
8
Bresnick, supra note 1.

2

What Genetic Testing Teaches About Long-Term Predictive Health
Analytics Regulation

heart disease, these might include drugs, exercise, and improved
diet.9
At the same time, predictive health analytics can also be
potentially harmful.10 Individuals who are identified as being at
high risk of developing future health problems such as cognitive
decline or opioid addiction may suffer psychological distress,
privacy violations (if the information is circulated to unauthorized
third parties), discrimination, and other harms.11 One scholar
worries that people labelled as being at high risk for suicide will be
Physicians might
treated differently by their physicians.12
discontinue beneficial medications for fear that they will exacerbate
the suicide risk, unnecessarily send police to patients’ homes,
forcibly hospitalize individuals, or relate to them in a demeaning,
dehumanizing way.13
Moreover, predictive health analytics outcomes can be
erroneous for a variety of reasons.14 Thus, individuals may endure
serious adverse consequences based on mistaken predictions, when
in truth there is no evidence that they are at risk of developing the
health problems at issue.
This Article argues that we are doing alarmingly little to
identify and address the ethical and legal implications of long-term
predictive health analytics. This is in stark contrast to policymakers’ thoughtful approach to the emergence of genetic testing
several decades ago.15
The Article highlights the discrepancy between society’s
relatively cautious approach to genetic testing and its more cavalier
approach to predictive analytics. It argues that scientists must
carefully consider the benefits and risks of predictive health
analytics and implement safeguards to address their hazards.
Data subjects should enjoy specified rights that give them a
degree of control over their data, including predicted health
outcomes. They should have an expanded right to consent to
9

Strategies to Prevent Heart Disease, MAYO CLINIC (Jan. 9, 2019),
https://www.mayoclinic.org/diseases-conditions/heart-disease/in-depth/heartdisease-prevention/art-20046502.
10
See infra Part IV.
11
Id.
12
Mason Marks, Artificial Intelligence Based Suicide Prediction, YALE J.
HEALTH POL’Y L. & ETHICS __ (forthcoming)
13
Id. at __.
14
See infra Part IV.
15
See infra Part III.
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disclosure of their health information, a right to discover who has
seen their health data, and a right to sue for privacy breaches that
harm them and for discrimination based on disease predictions.16
The scientific community should also develop an oversight
mechanism to safeguard the quality of predictive models.17
The remainder of the Article proceeds as follows. Part II
describes long-term predictive health analytics and illustrates the
work that scientists are conducting in this area. Part III analyzes the
precedent of genetic testing, focusing on the concerns that it raised
and the measures that policy-makers implemented to address them.
Part IV examines the risks of long-term predictive health analytics.
Part V develops preliminary recommendations for responsive legal
and policy changes. Part VI concludes.

II.

LONG-TERM PREDICTIVE HEALTH ANALYTICS

A. Predictive Health Analytics Defined
Predictive analytics can be defined as “the analysis of large data
sets to discover patterns and use those patterns to forecast or predict
the likelihood of future events.”18 Experts conduct this analysis
using computer algorithms.19 An algorithm is a precise step-by-step
process that leaves nothing to guesswork or intuition.20 Learning
algorithms train predictive models using training sets comprised of
sample input and output values.21 Some analysts use the term
“predictive modeling” which can be defined as “the process of
developing a mathematical tool or model that generates an accurate
prediction.”22 Researchers often use the terms “learning algorithm”
and “predictive model” interchangeably, although the term
“predictive model” suggests a representation of knowledge that is

16

See infra Part V.A.1 & 2.
See infra Part V.B.1.
18
David Crockett et al., What is Data Mining in Healthcare? HEALTHCATALYST
(2017)
https://www.healthcatalyst.com/wp-content/uploads/2014/06/What-isdata-mining-in-healthcare.pdf.
19
I. Glenn Cohen et al., supra note 5, at 1139; Nicholson Price, Regulating BlackBox Medicine, 116 MICH. L. REV. 421, 425-26 (2017) (discussing the nature of
medical algorithms).
20
Deven R. Desaia & Joshua A. Kroll, Trust but Verify: A Guide to Algorithms
and the Law, 31 HARV. J.L. & TECH. 1, 23 (2017).
21
SHAI SHALEV-SHWARTZ & SHAI BEN DAVID, UNDERSTANDING MACHINE
LEARNING 13-14 (2014) (discussing “the statistical learning framework”).
22
MAX KUHN & KJELL JOHNSON, APPLIED PREDICTIVE MODELING 2 (2013).
17
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created by an algorithm.23 Predictive analysis is based on
techniques from three closely related areas of research: statistical
inference, data mining, and machine learning.
Statistical inference involves analyzing a dataset and, based
on this sample, inferring properties of a larger population and
characterizing uncertainties about them.24 Data mining is the
process of using algorithms to examine “big data” from sources such
as databases or the Internet in order to unearth hidden knowledge or
patterns.25 “Big data” can be defined as data that is of high volume,
variety, and velocity, the latter of which refers to the speed with
which it is generated.26 In medicine, big data can come from a
myriad of sources, including patients, health care providers,
insurers, manufacturers, the government, and even mobile devices
such as smartphones and wearables.27
Machine learning refers to methods that enable computers to
“automatically detect patterns in data, and then use the uncovered
patterns to predict future data, or to perform other kinds of decisionmaking under uncertainty.”28 Scientists train computers to do
analytical work by feeding them information, such as patients’
medical records.29 For example, scientists might show computers a
large number of tumor images with indications as to which ones are
23

See supra notes 21-22 and accompanying text.
WILLIAM L. HAYS, STATISTICS 1 (4TH ed. 1988) (describing statistical inference
as a process of analysis that enables one to “make general statements about the
large body of potential observations, of which the data collected represents but a
sample”);
Statistical
Inference,
OXFORD
LIVING
DICTIONARIES,
https://en.oxforddictionaries.com/definition/us/statistical_inference (last visited
Feb. 25, 2019) (defining statistical inference as “[t]he theory, methods, and
practice of forming judgments about the parameters of a population and the
reliability of statistical relationships, typically on the basis of random sampling”).
25
JIAWEI HAN ET AL., DATA MINING: CONCEPTS AND TECHNIQUES 8 (3RD ED.
2012).
26
SHARONA HOFFMAN, ELECTRONIC HEALTH RECORDS AND MEDICAL BIG DATA:
LAW AND POLICY 111 (2016).
27
Nathan Cortez, Substantiating Big Data in Health Care, 14 I/S: J.L. & POL’Y
FOR INFO. SOC’Y 61, 63-65 (2017) (discussing the breadth of big data sources).
28
KEVIN P. MURPHY, MACHINE LEARNING: A PROBABILISTIC PERSPECTIVE 1
(2012). See also, David Lehr & Paul Ohm, Playing with the Data: What Legal
Scholars Should Learn about Machine Learning, 51 U.C. DAVIS L. REV. 653, 671
(2017) (“Fundamentally, machine learning refers to an automated process of
discovering correlations (sometimes alternatively referred to as relationships or
patterns) between variables in a dataset, often to make predictions or estimates of
some outcome.”).
29
See Niha Beig et al., Perinodular and Intranodular Radiomic Features on Lung
CT Images Distinguish Adenocarcinomas from Granulomas, 290 RADIOLOGY
783, 784 (2019) (relating that a “machine classifier was trained on a cohort of 145
patients”).
24
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cancerous and which ones are not.30 The computers then learn to
differentiate between benign and malignant tumors based on
patterns in the tumor x-rays or scans, so that they can identify
cancerous tumors when shown new images.31
A well-known type of machine learning is deep learning,
which allows computers “to learn from experience and understand
the world in terms of a hierarchy of concepts, with each concept
defined through its relation to simpler concepts.”32 Thus, computers
gather knowledge from experience and learn more complex
concepts by building on simpler concepts.33 Many readers will be
familiar with the general term “artificial intelligence,” which refers
to computers’ ability to mimic human behavior and learn.34
Predictive models are valuable for physicians, researchers,
and policy makers.35 They can help public health officials identify
those who are at highest risk of developing a disease so they can
implement preventive interventions for them.36 In the clinical
setting, predictive models may discern which patients are likely to
have poor and successful treatment outcomes so physicians can
tailor their medical decisions accordingly. Predictive analytics may
also help identify high-risk individuals whom doctors should
aggressively screen for particular diseases.37
In addition, predictive health analytics can generate
projections regarding the health problems that will plague
individuals in the future.38 These long-term forecasts are the subject
of this Article. Such predictions can be beneficial to patients if
physicians can offer medical interventions to prevent or detect the
condition at issue at a very early stage. However, such predictions
can also render the data subject vulnerable to adverse psychological
consequences, discrimination, and other harms.39

30

Id.
Id. at 792.
32
IAN GOODFELLOW ET AL., DEEP LEARNING 2 (2016).
33
Id.
34
Id.
35
EWOUT W. STEYERBERG, CLINICAL PREDICTION MODELS 1-3, 11 (2009).
36
Id. at 11-12.
37
Id.
38
See infra Parts II.B. and C.
39
See infra Part IV.
31
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B. Long-Term Predictive Health Analytics Examples
aScientists are working hard to identify physical and behavioral
clues to individuals’ future health status. Many studies focus on the
question of whether there are traits, habits, or other indicators that
signal that a person is vulnerable to particular diseases in the future.
Medical researchers are investigating biomarkers that can help
them discern disease risks. A “biomarker” is a “biological molecule
found in blood, other body fluids, or tissues that is a sign of a normal
or abnormal process, or of a condition or disease.”40 For example,
researchers reported in 2014 that in their study, people with lower
levels of ten phospholipids in their blood were at higher risk of
suffering cognitive impairments at the time of the blood draw or
within a few years.41
A 2018 study found that retinopathy was associated with
higher rates of cognitive decline over the next twenty years.42
Retinopathy is a disease that involves the small retinal blood vessels
in the eye.43
Human eyes can also reveal information about cardiovascular
risks. As reported in 2018, researchers from Google and its healthtech subsidiary, Verily, used machine learning to analyze eye scans
and medical data from nearly 300,000 patients in order to develop
an algorithm that can predict individuals’ risk of heart disease.44

NCI Dictionary of Cancer Terms, NAT’L CANCER INST.,
www.cancer.gov/publications/dictionaries/cancer-terms?cdrid=45618
(last
visited Mar. 7, 2019).
41
Alison Abbott, Biomarkers Could Predict Alzheimer’s Before It Starts,
NATURE, Mar. 9, 2014, available at www.nature.com/news/biomarkers-couldpredict-alzheimer-s-before-it-starts-1.14834.
42
Jennifer A. Deal et al., Retinal Signs and 20-year Cognitive Decline in the
Atherosclerosis Risk in Communities Study, 90 NEUROLOGY e1158, e1158 (2018).
The study involved 12,317 men and women who were 50 to 73 years of age when
they were first examined.
43
Janet M. Torpy et al., Retinopathy, 298 JAMA. 944, 944 (2007).
44
Ryan Poplin et al., Prediction of Cardiovascular Risk Factors from Retinal
Fundus Photographs via Deep Learning, 2 NATURE BIOMEDICAL ENGINEERING
158, 158 (2018); James Vincent, Google’s New AI Algorithm Predicts Heart
Disease by Looking at Your Eyes, THE VERGE (Feb. 19, 2018) (“As with all deep
learning analysis, neural networks were then used to mine this information for
patterns, learning to associate telltale signs in the eye scans with the metrics
needed to predict cardiovascular risk (e.g., age and blood pressure).”).
40
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IBM researchers “identified an automated machine-learning
speech classifier” that could predict psychosis based on the speech
patterns of high-risk patients.45 The technique relied on indicators
such as less semantic coherence and diminished use of possessive
pronouns, and it reportedly achieved an eighty-three percent
accuracy rate.46
Electronic documentation has been particularly helpful for
purposes of health predictions. In 2014, IBM announced that it had
analyzed electronic health records from Virginia’s Carilion Clinic
and been able to identify 8,500 patients who were at risk of heart
failure.47 Scientists have also been able to use analysis of electronic
health records and medical claims data to predict which individuals
will develop depression or diabetes-related problems up to a year in
advance.48 The VA has launched a program called “VA Reach Vet”
by which it uses a predictive model to analyze veterans’ electronic
health records to identify individuals at high risk of suicide.49 The
Society of Actuaries used the Health Care Cost Institute database,
containing a seven-year record of insurance claims from forty-seven
million individuals, to predict which patients would have the highest
costs.50 It found that the most telling factor is prior cost history,
followed by age, gender, and prescription drug coverage.51

45

Cheryl M. Corcoran et al., Prediction of Psychosis Across Protocols and Risk
Cohorts Using Automated Language Analysis, 17 WORLD PSYCHIATRY 67, 67
(2018).
46
Id.
47
IBM Predictive Analytics to Detect Patients at Risk for Heart Failure, IBM
RELEASE,
Feb.
19,
2014,
available
at
;http://wwwNEWS
03.ibm.com/press/us/en/pressrelease/43231.wss; Mohana Ravindranath, IBM
Used Predictive Analytics to Find Patients at Risk of Heart Failure, WASH. POST,
Feb. 20, 2014, www.washingtonpost.com/business/on-it/ibm-used-predictiveanalytics-to-find-patients-at-risk-of-heart-failure/2014/02/20/9b0ddb3c-9a4711e3-b88d-f36c07223d88_story.html
48
Arthur Allen, Big Brother Is Watching Your Waist, POLITICO (July 21, 2014),
www.politico.com/story/2014/07/data-mining-health-care-109153.
49
VA REACH VET Initiative Helps Save Veterans Lives:
Program Signals When More Help Is Needed for At-Risk Veterans, U.S. DEP’T
VETERANS
AFFAIRS
(Apr.
3,
2017),
https://www.va.gov/opa/pressrel/includes/viewpdf.cfm?id=2878.
50
Brian Hartman et al., Predicting High-Cost Members in the HCCI Database
(July
20,
2018)
(unpublished
manuscript),
available
at
https://hartman.byu.edu/files/HartmanOwenGibbs_HighCostClaims.pdf.
51
Id. at 4.
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C. Non-Traditional Data Sources for Predictive Health
Analytics
Social media has become an increasingly common source of
data used for predictive health analytics. Researchers recently
reported that they used an algorithm to analyze Facebook data from
close to 1200 consenting users and identified linguistic signals that
could predict depression.52
Facebook itself has joined the fray of predictive health analytics.
Its software now monitors users’ posts to identify those with suicidal
intent, and an algorithm assigns a risk score ranging from zero to
one.53 The algorithm interprets phrases such as “Are you okay?”
paired with “Goodbye” and “Please don’t do this” as clues that
someone is in distress.54 In cases it assesses as severe, Facebook
contacts the police, as it did at least 3,500 times in 2018.55
Unfortunately, police officers who are poorly trained or
inexperienced may mishandle such “wellness checks,” exacerbating
the situation and in extreme cases, using deadly force against
individuals with mental illness.56
Analysts are turning to other nontraditional data sources as well.
For example, several years ago, Carolinas Healthcare (now Atrium
Health) purchased consumer information from data brokers57 in an
52

Johannes C. Eichstaedt et al., Facebook Language Predicts Depression in
Medical Records, 115 PNAS 11203, 11203, 11207 (2018).
53
Martin Kaste, Facebook Increasingly Reliant on A.I. To Predict Suicide Risk,
NPR (Nov. 17, 2018), https://www.npr.org/2018/11/17/668408122/facebookincreasingly-reliant-on-a-i-to-predict-suicide-risk; Benjamin Goggin, Inside
Facebook's Suicide Algorithm: Here's How the Company Uses Artificial
Intelligence to Predict Your Mental State from Your Posts, BUS. INSIDER (Jan. 6,
2019), https://www.businessinsider.com/facebook-is-using-ai-to-try-to-predictif-youre-suicidal-2018-12.
54
Mason Marks, Suicide Prediction Technology Is Revolutionary. It Badly Needs
Oversight,
WASH.
POST,
Dec.
20,
2018,
https://www.washingtonpost.com/outlook/suicide-prediction-technology-isrevolutionary-it-badly-needs-oversight/2018/12/20/214d2532-fd6b-11e8-ad40cdfd0e0dd65a_story.html?utm_term=.951089ae3f76.
55
Kaste, supra note 53.
56
Marks, supra note 12, at ___.
57
Data brokers are “companies that collect information, including personal
information about consumers, from a wide variety of sources for the purpose of
reselling such information to their customers for various purposes . . . .” FEDERAL
TRADE COMMISSION, PROTECTING CONSUMER PRIVACY IN AN ERA OF RAPID
CHANGE
68
(2012),
available
at
https://www.ftc.gov/sites/default/files/documents/reports/federal‐trade‐
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effort to use algorithms that identify high-risk patients.58
Information garnered from credit card purchasing records or grocery
loyalty cards can indicate whether individuals are buying healthy
food, smoking, refilling their prescriptions, and have gym
memberships.59 These data in turn can predict the likelihood that
someone will have a severe asthma attack or a heart attack.60
The University of Pittsburgh Medical Center has used patient
demographic and household information to predict health risks.61 It
concluded that people who do not reside with children in the home
and earn less than $50,000 annually are more likely to visit
emergency rooms rather than to make an appointment with a private
doctor, which is a much cheaper way to obtain appropriate
treatments for many conditions.62 Likewise, individuals without a
car may not be receiving adequate medical care.63 Healthcare
systems assert that they use such information in order to implement
preventive and corrective interventions for patients.64 However,
skeptics have questioned their true motivations, suspecting that cost
savings are at the heart of the matter and worrying that data mining
practices compromise patient privacy and damage the physicianpatient relationship.65
D. Predictive Health Analytics as Big Business
Predictive health analytics have generated business
opportunities for enterprising organizations. Companies are
reportedly selling “risk scores” to health care providers and insurers
to identify patients who are at risk of becoming addicted to or
commission‐report‐protecting‐consumer‐privacy‐era‐rapid‐change‐
recommendations/120326privacyreport.pdf. See also Janine S. Hiller, Healthy
Predictions? Questions for Data Analytics in Health Care, 53 AM. BUS. L.J. 251,
271-72 (2016) (discussing data brokers and health data streams).
58
Melanie Hicken, Big Data: Look Who's Buying Your Personal Information,
CNN MONEY, Sept. 10, 2014, https://money.cnn.com/gallery/pf/2014/09/07/bigdata-personal-information/3.html; Shannon Pettypiece & Jordan Robertson,
Hospitals, Including Carolinas HealthCare, Using Consumer Purchase Data for
Information on Patient Health, THE CHARLOTTE OBSERVER, June 27, 2014,
https://www.charlotteobserver.com/living/health-family/article9135980.html.
59
Pettypiece & Robertson, supra note 58.
60
Id.
61
Id.
62
Id.
63
Id.
64
Id.
65
Id. See supra Part IV for discussion of concerns raised by predictive analytics.
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overdosing on opioids.66 Business giants such as LexisNexis collect
data from insurance claims, electronic health records, housing
information, and records relating to patients’ social and family
connections in order to produce risk scores.67 They do all this
without asking patients for permission and are not required to seek
consent by law.68
Data brokers sell other types of information to health care
providers as well. LexisNexis and Acxiom sell assessments of
patients based on “criminal records, online purchasing histories,
retail loyalty programs and voter registration data.”69 This
information is used to identify individuals who are at risk of
requiring costly care or readmission to a hospital.70
Moreover, data brokers routinely supply predictive health
information to parties outside the health care industry as well. They
garner data from a myriad of sources such as publicly available
records, surveys, shopper loyalty programs, social media, magazine
subscription lists, fitness devices, people’s Internet searches, and
more.71 They then organize and sell the data, often with personally
identifying information, to interested third parties, including
marketers.72 These buyers can use the medical information for

66

Mohana Ravindranath, How Your Health Information Is Sold and Turned into
‘Risk
Scores’,
POLITICO
(Feb.
3,
2019),
https://www.politico.com/story/2019/02/03/health-risk-scores-opioid-abuse1139978. See also, Timothy R. Hylan et al., Automated Prediction of Risk for
Problem Opioid Use in a Primary Care Setting, 16 J. PAIN 380, 385 (2015)
(discussing use of electronic health records to develop “simple risk stratification
algorithms to initially alert clinicians to … patients at higher risk for problem
opioid use”).
67
Ravindranath, supra note 66.
68
Id. See supra notes 142-143 and accompanying text for a discussion of the
limitations of the HIPAA Privacy Rule.
69
Mohana Ravindranath, Does Your Doctor Need to Know What You Buy on
Amazon?,
POLITICO
(Oct.
30,
2018),
https://www.politico.com/story/2018/10/30/the-doctor-will-see-through-younow-893437.
70
Id.
71
Adam Tanner, Strengthening the Protection of Patient Medical Data, THE
CENTURY
FOUNDATION
(Jan.
10,
2017),
https://tcf.org/content/report/strengthening-protection-patient-medicaldata/?agreed=1; Sam Thielman, Your Private Medical Data Is for Sale – and It's
Driving a Business Worth Billions, THE GUARDIAN (Jan. 17, 2017),
https://www.theguardian.com/technology/2017/jan/10/medical-datamultibillion-dollar-business-report-warns.
72
Tanner, supra note 71.
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purposes of predictive analytics, to predict individuals’ future
behaviors and health needs.73
III.

THE PRECEDENT OF GENETIC TESTING

Predictive health analytics are novel and exciting, but they
are not the first mechanism used to predict future health problems.
A much more familiar and well-established technique is genetic
testing, also known as DNA testing.74 When genetic testing
emerged as a prevalent diagnostic and predictive tool, it raised
significant ethical, legal, and policy concerns. There is much to be
learned from the conversations and interventions that followed.
A. Predictive Genetic Testing
In the late 1960s scientists developed the ability to test fetuses
for Down’s syndrome through a sample of amniotic fluid.75 Fetal
genetic testing became common beginning in the 1970s, and today
it is used to screen for Tay-Sachs disease, sickle cell disease, cystic
fibrosis, and many other illnesses.76
Genetic testing can also analyze disease risks after birth and
provide information regarding the likelihood that individuals will
develop specific maladies in the future.77 In 1990, Mary King-

73
Russ Cobb, 2018: Taking Your Healthcare System Marketing Strategies into
the Consumer Age, BECKER’S HOSPITAL REV. (Dec. 19, 2017),
https://www.beckershospitalreview.com/patient-engagement/2018-taking-yourhealthcare-system-marketing-strategies-into-the-consumer-age.html. Thielman,
supra note 71.
74
Wylie Burke, Genetic Testing, 347 NEW ENG. J. MED. 1867, 1867 (2002) ;
Frequently Asked Questions about Genetic Testing, NAT’L HUMAN GENOME
RESEARCH INST., https://www.genome.gov/19516567/faq-about-genetic-testing/
(last updated Feb. 13, 2019) (“Genetic testing uses laboratory methods to look at
your genes, which are the DNA instructions you inherit from your mother and
your father. Genetic tests may be used to identify increased risks of health
problems, to choose treatments, or to assess responses to treatments.”); Genetic
Testing: How It Is Used for Healthcare, DEP’T OF HEALTH & HUMAN SERVS.,
https://report.nih.gov/nihfactsheets/ViewFactSheet.aspx?csid=43 (last updated
June 30, 2018).
75
Glenn E. Palomaki, Screening for Down’s Syndrome, 333 NEW ENGL. J. MED.
532 (1995).
76
Nancy Press, Genetic Testing and Screening, in FROM BIRTH TO DEATH AND
BENCH TO CLINIC: THE HASTINGS CENTER BIOETHICS BRIEFING BOOK FOR
JOURNALISTS, POLICYMAKERS, AND CAMPAIGNS 73 (Mary Crowley ed., The
Hastings Center, 2008).
77
LORI B. ANDREWS ET AL., GENETICS: ETHICS, LAW, AND POLICY 301 (2015);
What Are the Types of Genetic Tests?, U.S. NAT’L LIBRARY OF MED.,
https://ghr.nlm.nih.gov/primer/testing/uses (published Feb. 26, 2019).
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Claire identified a genetic mutation,78 BRCA1, that is linked to
breast and ovarian cancer, as is BRCA2, which was discovered
shortly thereafter.79 Since then, scientists have discovered a myriad
of genetic abnormalities that can increase disease vulnerabilities and
have developed predictive genetic tests for some of them.80 For
example, predictive testing can be done for early-onset familial
Alzheimer’s disease, a variety of cancers, hereditary
hemochromatosis (a disorder causing iron overload), Huntington’s
Disease, and more.81
B. Genetic Testing Concerns
The advent of genetic testing raised numerous concerns that
were vigorously debated and catapulted professional and
governmental bodies into action. Academics wrote hundreds of
articles about genetic testing, and law reviews dedicated entire
symposium issues to the subject.82 In 1995 the National Institutes
78

A mutation “is a permanent alteration in the DNA sequence that makes up a
gene, such that the sequence differs from what is found in most people.” What Is
a Gene Mutation and How Do Mutations Occur?, U.S. NAT’L LIBRARY OF MED.,
https://ghr.nlm.nih.gov/primer/mutationsanddisorders/genemutation (published
Feb. 26, 2019).
79
Nancy Press, supra note 76, at 73; Lydia Ramsey, Over a 40-Year Career, This
'Stubborn Scientist' Helped Change the Way We Think about Cancer and
Genetics, BUS. INSIDER (Nov. 16, 2017), https://www.businessinsider.com/maryclaire-king-and-the-impact-brca-genes-had-on-cancer-genetics-2017-11; BRCA1
& BRCA2 Genes: Risk for Breast & Ovarian Cancer, MEM’L SLOAN KETTERING
CANCER
CTR.,
https://www.mskcc.org/cancer-care/risk-assessmentscreening/hereditary-genetics/genetic-counseling/brca1-brca2-genes-risk-breastovarian (last visited Feb. 27, 2019).
80
ANDREWS ET AL., supra note 77, at 301; Burke, supra note 74, at 1870.
81
Burke supra note 74, at 1870; Learning About Huntington's Disease, NAT’L
HUMAN GENOME RESEARCH INST., https://www.genome.gov/10001215/learningabout-huntingtons-disease/ (last updated: Nov. 17, 2011); What Are the Types of
Genetic Tests?, supra note 77.
82
See, e.g., The Fifth Annual Health Law Symposium, Communities of Color and
Genetic Testing: Purpose, Voice, & Values, 27 SETON HALL L. REV. 887 (1997);
Symposium, The Genetics Revolution: Conflicts, Challenges and Conundra, 28
AM. J.L. & MED. 145 (2002); Symposium, The Human Genome Initiative and the
Impact of Genetic Testing and Screening Technologies, 17 AM. J.L. & MED. 1
(1991); Symposium, Is There a Pink Slip in Your Genes? Genetic Discrimination
in Employment and in Health Insurance, 16 J.L. & HEALTH 1 (2001-02);
Symposium, Legal and Ethical Issues Raised by the Human Genome Project, 29
HOUS. L. REV. 1 (1992); Symposium, Legal Liabilities at the Frontier of Genetic
Testing (pts. 1 & 2), 41 JURIMETRICS 1 (2000), 41 JURIMETRICS 145 (2001);
Symposium, Living in the Genetic Age: New Issues, New Challenges, 3 ST. LOUIS
U. J. HEALTH L. & POL’Y 1 (2009); The Randolph W. Thrower Symposium, Law
& Human Genetics on the Threshold of the New Millennium, 49 Emory L.J. 745
(2000); Symposium, Re-defining Disability: Legal Protections for Individuals
with HIV, Genetic Predispositions to Disease, or Asymptomatic Diseases, 3 J.
HEALTH CARE L. & POL’Y 225 (2000); Symposium, Testing and Telling?:
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of Health-Department of Energy Joint Working Group on the
Ethical, Legal and Social Implications of Human Genome Research
established a Task Force on Genetic Testing.83 The American
Academy of Ophthalmology convened such a task force as well.84
For purposes of illustration, this section will focus on three areas of
concern out of the many that were considered: clinical validity and
predictive accuracy; privacy and discrimination; and psychological
harms.
1. Clinical Validity and Predictive Accuracy
Experts worry about the clinical validity and predictive
accuracy of genetic test results.85 Many genetic tests identify only
a fraction of genetic mutations that can cause a disease because
researchers have yet to discover other mutations or because the price
of more comprehensive testing is too high.86 Moreover, although a
subgroup of patients may have an inherited form of a disease such
as cancer, many others will develop the disease because of
environmental or other triggers without having genetic mutations.87
Individuals who undergo genetic testing and receive negative results
may mistakenly conclude that they are immune to the disease at
issue. Thus, a woman who is found not to have the BRCA1 or
BRCA2 mutation may foolishly decline appropriate screening
measures, such as routine mammograms and gynecological exams.
In truth, only five to ten percent of breast and ovarian cancers are
hereditary, so the vast majority of these diseases have no genetic
link.88
A further risk is that the opposite will occur. An individual
who receives a positive genetic test result may panic and take
unnecessarily aggressive preventive measures.89 Many genetic
mutations are not completely penetrant, that is, not all individuals
with the abnormality will develop the disease at issue.90 For
Implications for Genetic Privacy, Family Disclosure and the Law, 1 J. HEALTH
CARE L. & POL’Y 301 (1998).
83
Task Force on Genetic Testing, NAT’L HUMAN GENOME RESEARCH INST. (Apr.
1995), https://www.genome.gov/10001808/genetic-testing-task-force/.
84
See Edwin M. Stone et al., Recommendations for Genetic Testing of Inherited
Eye Diseases, 119 Ophthalmology 2408 (2012).
85
Burke supra note 74, at 1871.
86
Id.
87
BRCA1 & BRCA2 Genes: Risk for Breast & Ovarian Cancer, supra note 79.
88
Id.
89
ANDREWS ET AL., supra note 77, at 301.
90
What Are Reduced Penetrance and Variable Expressivity?, U.S. NAT’L
LIBRARY
OF
MED.,
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example, a woman who tests positive for the BRCA1 mutation has
only a fifty-five to sixty five percent chance of developing breast
cancer by the age of seventy.91 Women who fully understand the
meaning of their test results and the extent of their risk may or may
not want to undergo prophylactic radical mastectomies, and either
decision would be rational.
Physicians and patients who use genetic testing must be fully
educated about how to interpret test results and the limitations of the
information they reveal. It is all too easy to misconstrue test
outcomes and attribute more certainty to genetic predictions than
they warrant. Such misunderstandings can lead to consequential
medical treatment missteps.
2. Privacy and Discrimination
A dearth of regulation that protected patients against medical
privacy violations and genetic discrimination led to significant
concern in legal and policy circles for several decades.92 Until 2003,
there was no federal law that safeguarded the privacy of health
information in general, let alone genetic information in particular.93
Thus, federal law did not prohibit anyone who possessed genetic
information from disclosing it to third parties. At the state level, a
patchwork of statutes offered varying degrees of genetic privacy
protections in some states.94 Moreover, until the passage of the
Genetic Information Nondiscrimination Act in 2008,95 no federal
law prohibited third parties such as employers and health insurers
https://ghr.nlm.nih.gov/primer/inheritance/penetranceexpressivity
(published
Feb. 26, 2019) (“Penetrance refers to the proportion of people with a particular
genetic change (such as a mutation in a specific gene) who exhibit signs and
symptoms of a genetic disorder.”).
91
BRCA1
and
BRCA2,
SUSAN
G.
KOMEN,
https://ww5.komen.org/BreastCancer/BRCA1andBRCA2.html (updated Dec. 7,
2018).
92
See generally, Eric Mills Holmes, Solving the Insurance/Genetic Fair/Unfair
Discrimination Dilemma in Light of the Human Genome Project, 85 KY. L.J. 503
(1997); Pauline T. Kim, Genetic Discrimination, Genetic Privacy: Rethinking
Employee Protections for a Brave New Workplace, 96 NW. U. L. REV. 1497
(2002).
93
HOFFMAN, supra note 26, at 62 (discussing the HIPAA Privacy Rule, which
became effective in 2003); Karen H. Rothenberg, Breast Cancer, The Genetic
“Quick Fix,” and The Jewish Community: Ethical, Legal, and Social Challenges,
7 HEALTH MATRIX 97, 115 (1997).
94
Lori B. Andrews, A Conceptual Framework for Genetic Policy: Comparing the
Medical, Public Health, and Fundamental Rights Models, 79 WASH. U. L.Q. 221,
280 (2001); Rothenberg, supra note 93, at 115-18;
95
Genetic Information Nondiscrimination Act of 2008, Pub. L. No. 110-233, 122
Stat. 881 (codified as amended in scattered sections of 29 & 42 U.S.C.).
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from demanding that individuals provide genetic information or
from discriminating on its basis.96 Some states took the lead and
passed genetic discrimination legislation as early as the 1990s, but
the protections they offered were inconsistent and often limited.97
Without comprehensive privacy protection, sensitive genetic
information could end up in the hands of third parties that could use
it to promote their own agendas. The prospect of genetic
discrimination generated a plethora of literature and many heated
academic and policy debates.98
For example, workers worried that employers would obtain
genetic data through pre-employment or post-employment medical
examinations.99
Once they learned of individuals’ genetic
abnormalities, employers could decide to reject them, fire them,
demote them, or take other adverse actions with impunity.100
Americans also were apprehensive about the impact of genetic
testing on health insurance coverage.101 An insurer selling an
individual policy who obtained data about an applicant’s disease
risks could potentially decline to insure the person, raise premium
prices, or dictate other adverse coverage conditions.102 The same
could be true for other types of insurance, such as long-term care
plans.103
3. Psychological Harms
A third area of concern revolved around psychological harms.
Individuals who discover that they are at risk of a life-threatening
disease may suffer depression and even become suicidal.104 They
96

Rothenberg, supra note 93, at 107-114.
Id. at 108-09, 114-15.
98
See supra notes 82-84 and accompanying text.
99
Ellen R. Peirce, The Regulation of Genetic Testing in the Workplace – A
Legislative Proposal, 46 OHIO ST. L.J. 771, 801-04 (1985).
100
Id.
101
Andrews, supra note 94, at 258-61.
102
Id. at 280 (explaining that the law “does not prohibit genetic discrimination
against people seeking insurance under individual plans” and “does not prohibit
group insurers from charging higher rates to a whole group
based on genetic information about a particular individual”); Robert Lowe,
Genetic Testing and Insurance: Apocalypse Now? 40 DRAKE L. REV. 507, 51011 (1991).
103
Mark A. Rothstein, Predictive Genetic Testing for Alzheimer's Disease in
Long-Term Care Insurance, 35 GA. L. Rev. 707 (2001).
104
Katherine A. Schneider, Adverse Impact of Predisposition Testing on Major
Life Activities: Lessons from BRCA1/2 Testing, 3 J. HEALTH CARE L. & POL’Y
365, 369 & 372-74 (2000); Kathryn M. Kash, Psychosocial and Ethical
97
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may lose motivation to be productive in their careers, experience
diminished self-esteem, and have difficulty caring for their
families.105 They may also decide not to get married or have
children because they expect to die young and do not wish to
transmit a genetic abnormality to a child.106 On the other hand, some
patients expect to develop inherited diseases such as breast cancer
or Huntington’s disease because many of their family members
suffered from the condition, and they build their lives around this
assumption.107 Obtaining a negative genetic test result may be just
as devastating to them.108 They may be confused and depressed by
the need to reorient their lives and feel “survivors’ guilt” in the face
of their loved ones’ suffering.109
The risk of psychological injury is particularly acute in the case
of testing minors, especially for adult-onset illnesses, such as
Huntington’s disease.110 Experts questioned whether it was ethical
to test individuals under the age of eighteen.111 They also pondered
who should gain access to test results and the extent to which
clinicians should ask both parents and their children to consent to
the testing.112
If preventive measures such as regular screening and curative
medical interventions are available, genetic testing of children can
be justified and beneficial.113 However, in the absence of such
measures, many condemn testing as potentially devastating to
minors and their family members. Knowing that they live in the
shadow of an impending illness could ravage minors’ psychological

Implications of Defining Genetic Risk for Cancers, ANNALS N.Y. ACAD. SCI. 41,
45-6 (1995) (discussing “psychological issues in women at genetic risk”).
105
Schneider, supra note 104, at 369 & 372-74.
106
Id. at 376.
107
Id. at 374.
108
Id.
109
Id.
110
Kimberly A. Quaid, Genetic Testing for Huntington Disease, in 144
HANDBOOK OF CLINICAL NEUROLOGY 113, 115-17 (A.S. Feigin & K.E. Anderson
eds. 2017). For information about Huntington’s disease, see Huntington’s disease,
MAYO CLINIC, https://www.mayoclinic.org/diseases-conditions/huntingtonsdisease/symptoms-causes/syc-20356117 (last visited Mar. 3, 2019).
111
ANDREWS ET AL., supra note 77, at 331.
112
Id.
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Am. Soc’y of Human Genetics Bd. of Dirs. & Am. Coll. of Med. Genetics Bd.
of Dirs., Points to Consider: Ethical, Legal, and Psychosocial Implications of
Genetic Testing in Children and Adolescents, 57 AM. J. HUMAN GENETICS 1233,
1233 (1995).

17

What Genetic Testing Teaches About Long-Term Predictive Health
Analytics Regulation

wellbeing.114 Likewise, discovery of a child’s genetic abnormality
may upend family dynamics as the affected child is treated either as
more precious than others or less favorably because the child does
not have a promising future.115
C. Legal and Policy Interventions
As genetic testing became increasingly common, legislators and
other policy-makers implemented a variety of measures to address
the concerns that it raised. This section will focus on three of these:
federal and state anti-discrimination legislation, the HIPAA Privacy
Rule, and self-regulation mechanisms.
1. State and Federal Anti-Discrimination Legislation
States began enacting legislation that prohibits genetic
discrimination as early as the 1970s.116 Early laws focused on
protecting individuals with the sickle cell trait.117 In 1991,
Wisconsin was the first state to enact a more comprehensive
statute.118 Thereafter, the vast majority of states enacted genetic
anti-discrimination statutes, though they varied significantly in
scope and contents.119 As applied to health insurers, these laws
formulated restrictions related to using genetic information to
determine coverage eligibility or premium levels, requiring
applicants to undergo genetic testing, or disclosing genetic
information to others without consent.120 As applied to employers,
the laws prohibited employers from discriminating on the basis of
genetic information and from requesting, requiring, or obtaining
genetic information.121

114

Id. at 1235-36. At the same time, minors whose test results are negative “may
develop ‘survivor guilt,’ based on
the knowledge that one or more of their siblings will develop-and perhaps die
from-a serious genetic disease.” Id. at 1236.
115
Id. at 1236.
116
ANDREWS ET AL., supra note 77, at 776.
117
Id.
118
Id. See Wisconsin Fair Employment Law, WIS. STAT. § 111.372 (2018).
119
Genetics and Health Insurance State Anti-Discrimination Laws, NAT’L
CONFERENCE
OF
STATE
LEGISLATURES,
http://www.ncsl.org/research/health/genetic-nondiscrimination-in-healthinsurance-laws.aspx (last updated Jan. 2008) [hereinafter State Health Insurance
Discrimination Laws]; Genetic Employment Laws, NAT’L CONFERENCE OF STATE
LEGISLATURES,
http://www.ncsl.org/research/health/genetic-employmentlaws.aspx (last updated Jan. 2008) [hereinafter State Employment Discrimination
Laws].
120
State Health Insurance Discrimination Laws, supra note 119.
121
State Employment Discrimination Laws, supra note 119.
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The United States Congress considered genetic
discrimination bills for thirteen long years.122 Finally, President
George W. Bush signed the Genetic Information Nondiscrimination
Act (GINA) into law on May 21, 2008.123 GINA applies to the use
of predictive genetic information by health insurers and employers.
The law does not cover those who already manifest symptoms of a
genetic disease.124
Title I of the Act prohibits genetic discrimination in health
insurance. Health insurers offering group plans may not modify
premium prices and contribution amounts based on genetic
information.125 Insurers offering individual health plans may not
require genetic testing or use genetic information to establish rules
for eligibility, premium prices, or contribution amounts, or to apply
preexisting condition exclusions for coverage.126
GINA’s Title II focuses on employment discrimination. It
establishes that employers may not discriminate against employees
in hiring, firing, or other employment practices based on genetic
information.127 The law defines “genetic information” as including
genetic testing of both individuals and their family members and
family disease histories.128
Furthermore, Title II prohibits
employers from attempting to obtain genetic information about
applicants or employees by requesting, requiring, or purchasing
it.129
GINA has many critics who decry its arguably anemic
protections.130 For example, it applies only to health insurers and
ANDREWS ET AL., supra note 77, at 777.
Genetic Information Nondiscrimination Act of 2008, supra note 95; President
Bush Signs the Genetic Information Nondiscrimination Act of 2008, NAT’L
HUMAN
GENOME
RESEARCH
INST.
(May
21,
2008),
https://www.genome.gov/27026050/president-bush-signs-the-geneticinformation-nondiscrimination-act-of-2008/.
124
Mark A. Rothstein, GINA’s Beauty Is Only Skin Deep, GENE WATCH, Apr.May 2009, at 9, 10 (“The problem is that GINA only applies to asymptomatic
individuals.”).
125
29 U.S.C. § 1182(b)(3) (2010).
126
42 U.S.C. § 300gg-53 (2010).
127
42 U.S.C. § 2000ff-1(a) (2010).
128
42 USC § 2000ff(4)(A) (2010) (defining genetic information as “(i) an
individual’s genetic tests, (ii) the genetic tests of an individual’s family members,
and (iii) the manifestation of a disease or disorder in an individual’s family
members”)
129
42 U.S.C. § 2000ff-1(b) (2010).
130
See, e.g., Bradley A. Areheart & Jessica L. Roberts, GINA, Big Data, and the
Future of Employee Privacy, 128 YALE L.J. 710, 745 (2019) (noting that “the
scholarly reaction to GINA has been almost entirely negative”); Russell Korobkin
122
123

19

What Genetic Testing Teaches About Long-Term Predictive Health
Analytics Regulation

employers rather than to all parties that might possess genetic
information (such as life or disability insurers) and might subject
individuals to discrimination on its basis.131 GINA also does not
cover a range of non-genetic biologic information that may be of
interest to third parties, such as epigenetic markers and the
microbiome.132
A full analysis of GINA or parallel state legislation is beyond
the scope of this article. My point here is merely that legislators
recognized that genetic testing could yield both benefits and serious
risks. They were sufficiently thoughtful and concerned about those
risks to enact statutory interventions, however imperfect.
2.

The HIPAA Privacy Rule

The HIPAA Privacy Rule, which went into effect in 2003, is
a set of federal regulations that address the privacy of health
information.133 The Privacy Rule establishes that, with some
exceptions, covered entities134 must obtain patients’ permission to
disclose their protected health information to third parties.135 As of
2013, “health information” explicitly includes genetic
information.136
Under the HIPAA Privacy Rule, covered entities must allow
patients to view and obtain copies of their health records and receive

& Rahul Rajkumar, The Genetic Information Nondiscrimination Act — A HalfStep Toward Risk Sharing, 359 NEW ENG. J. MED. 335, 337 (2008) (criticizing
“[t]he arbitrary nature of the categories GINA creates”); Rothstein, supra note
124, at 9 (“Unfortunately, the protections afforded individuals under either state
laws prohibiting genetic discrimination in health insurance or GINA are not
particularly robust or valuable.”).
131
See supra notes 125-129 and accompanying text.
132
Areheart & Roberts, supra note 130, at 748-49.
133
45 C.F.R. §§ 160.101–534 (2018); HIPAA for Professionals, U.S. DEP’T OF
HEALTH
&
HUMAN
SERVS.,
https://www.hhs.gov/hipaa/forprofessionals/index.html (last reviewed June 16, 2017). The HIPAA Privacy Rule
was promulgated pursuant to the Health Insurance Portability and Accountability
Act of 1996 and was amended in accordance with the Health Information
Technology for Economic and Clinical Health (HITECH) Act of 2009. See 42
U.S.C. §§ 1320d to 1320d-9 (2010); Health Information Technology for
Economic and Clinical Health (HITECH) Act, Title XIII of Division A and Title
IV of Division B of the American Recovery and Reinvestment Act of 2009
(ARRA), Pub. L. No. 111-5 (Feb. 17, 2009).
134
See infra notes 142-143 for definition of covered entities.
135
45 C.F.R. §§ 164.508–.510 (2018).
136
45 CFR § 160.103 (2018); Genetic Information Privacy, ELEC. FRONTIER
FOUND., https://www.eff.org/issues/genetic-information-privacy (last visited
Mar. 6, 2019).
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an accounting of disclosures of their protected health information.137
In addition, patients can ask health care providers to correct errors
in their medical records or to use their health data restrictively.138 In
addition, covered entities that suffer privacy breaches of unsecured
data, such as hacking occurrences, must notify affected individuals
and the Department of Health and Human Services, and in instances
of large breaches, must also notify the media.139
The related HIPAA Security Rule, which became effective
in 2005, promotes secure storage and processing of electronic health
information (EHI).140 It delineates administrative, physical, and
technical safeguards to protect EHI’s confidentiality, integrity, and
availability.141
The HIPAA Privacy and Security Rules offer valuable
protections to American patients. However, like the genetic antidiscrimination statutes, they are limited in scope and have been
attacked by critics. For example, “covered entities” include only
health plans, health care clearinghouses, health care providers who
transmit health information electronically for purposes of HIPAArelevant transactions, and their business associates.142 Therefore,
other parties that possess and handle health information, such as data
brokers and marketers, need not comply with the Rules’ privacy and
security mandates.143
Another noteworthy regulatory gap in the HIPAA Privacy
and Security Rules is the absence of a private cause of action.144
Thus, individuals whose health data is breached cannot sue
wrongdoers for damages under federal law no matter what
consequences they suffer.
Instead, the regulations leave
enforcement solely in the hands of the Department of Health and
Human Services Office for Civil Rights (OCR) and state attorneys
137

45 C.F.R. §§ 164.520(b)(1)(iv), 164.528 (2018).
45 C.F.R. §§ 164.520(b)(1)(iv), 164.522 (2018).
139
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Unsecured protected health information means information “that is not rendered
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of a [specified] technology or methodology,” such as encryption.
140
Sharona Hoffman & Andy Podgurski, In Sickness, Health, and Cyberspace:
Protecting the Security of Electronic Private Health Information, 48 B.C. L. REV.
331, 335-36 (2007).
141
45 C.F.R. §§ 164.302–.318 (2018).
142
45 C.F.R. §§ 160.102–.103 (2018); 42 U.S.C. § 17934 (2010).
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See HOFFMAN, supra note 26, at 73.
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general offices, which may or may not have adequate staffing and
resources for robust prosecutorial activities.145
In addition, the HIPAA Privacy Rule features numerous
exceptions. Covered entities can disclose patients’ medical data for
purposes of treatment, payment, and health care operations without
patient authorization.146 Thus, the regulations permit physicians to
consult colleagues about patients and to ask administrators to review
records for billing or other office-related purposes without the
patients’ knowledge. The Rule exempts additional disclosures as
well, such as those made for law enforcement, public health, and
other listed purposes.147 In general, these exceptions are reasonable
and sound. However, patients should understand that they are often
ignorant of who is viewing their health data and for what purpose.
The HIPAA Privacy and Security Rules fall short of
providing American patients with comprehensive protection.
Nevertheless, they constitute important advances in the privacy
arena and address some of the concerns raised by genetic testing.
3. Self-Regulation
Genetic testing professionals also engage in self-regulation,
formulating practice guidelines and deferring testing until they have
educated patients about its potential consequences. For example,
The American Society of Breast Surgeons issued a “Consensus
Guideline on Genetic Testing for Hereditary Breast Cancer.”148 The
guidance formulated recommendations for genetic testing and
discussed testing limitations.149 The American Society of Human
Genetics Board of Directors and the American College of Medical
Genetics Board of Directors published a document entitled “Points
to Consider: Ethical, Legal, and Psychosocial Implications of
Genetic Testing in Children and Adolescents.”150 The guidance
recommended against testing children for adult-onset diseases if
they will derive no medical or psychological benefit from being
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tested as minors.151 The American College of Medical Genetics and
Genomics has issued practice guidelines related to genetic testing
for numerous conditions.152
Clinicians typically offer genetic counseling to patients who
are considering genetic testing.153 Counseling is designed to ensure
that patients make fully informed decisions about pursuing testing,
in light of the benefits and risks that exist in their particular
circumstances.154 A variety of health care providers can educate
patients about genetic testing, but a growing number of practices
include professional genetic counselors with master’s degrees.155
The American Board of Genetic Counselors has certified over 4,000
genetic counselors thus far.156 Thus, rather than rushing to test
patients after only a brief discussion, responsible clinicians exercise
a degree of self-restraint and take steps to ensure that patients
provide meaningful and genuinely informed consent to the
procedure.

IV.

LONG-TERM PREDICTIVE HEALTH ANALYTICS
CONCERNS

Like genetic testing, long-term predictive health analytics are
fraught with risks, but these are garnering too little attention.157 This
section highlights three areas of concern, though this list is far from
comprehensive. It focuses on psychological harms, privacy and
discrimination, and erroneous predictions.
A. Psychological Harms
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guidelines for Huntington’s disease, including those addressing predictive testing
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Predictions of future ailments based on predictive health
analytics can be just as traumatizing as predictions based on genetic
testing.158 Individuals who learn from their doctors that they are
likely to develop heart disease, dementia, or psychosis in the future
might feel that the news is devastating.159 As a result, they could
have difficulty concentrating on work, experience strain in their
relationships, or even become clinically depressed or suicidal.160
Like genetic testing of children, predictive health analytics
involving minors raise particularly troubling questions.161
Worrisome predictions can adversely impact children’s futures and
disrupt family dynamics.162
Physicians who identify certain individuals as vulnerable to
opioid addiction, cognitive decline, or suicide163 may treat those
patients differently, to the patients’ detriment. For example, they
may refuse to provide potential opioid addicts with needed pain
medication.164 They may also relate to patients at risk of dementia
or suicide poorly, treating them as cognitively compromised or
lacking autonomy even when they are fully competent.165 So too
they may try to drive patients who are labelled as potentially highrisk and high-cost away from their practices.166
It is also likely that many individuals will obtain distressing
health predictions not from their doctors, but from commercial
enterprises, without being aware in advance that anyone has
assessed their health risks. Data brokers sell health information to
interested buyers, and companies such as LexisNexis and Acxiom
have already begun to engage in predictive health analytics.167
Marketers will likely be eager to obtain health predictions about
patients in order to tailor their marketing materials effectively.168
Imagine individuals receiving the news that they are at risk of
cognitive decline through an electronic advertisement urging them
to purchase memory-enhancing products! People who do not have
158
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the support of a physician and do not receive a clear, medical
explanation of the prediction and its degree of certainty will be all
the more vulnerable to distress and misunderstandings.

B. Privacy and Discrimination
Because the HIPAA Privacy Rule governs only a subset of
parties that possess health information,169 not all predictive health
analytics outcomes will be subject to privacy protections.170 Entities
that are not health plans, health care clearinghouses and health care
providers or their business associates are not legally bound to refrain
from disclosing health information about patients.171 Thus, data
brokers are permitted to sell health-related information to
marketers.172 Moreover, entities that are not covered by HIPAA
could disclose and publicize individually identifiable predictive
health analytics results. One can imagine the media obtaining
predictions about entertainers and politicians that can cause
significant embarrassment and even ruin careers. Predictions about
ordinary people could likewise be widely publicized through social
media and be available to anyone with an electronic device.
It is also noteworthy that non-covered entities are not subject to
the requirements of the HIPAA Security Rule.173 Thus, such entities
may be tempted to use security shortcuts and may be vulnerable to
hacking and other data breaches.174 Data stored by commercial
enterprises for predictive health analytics purposes, consequently,
may be more vulnerable to privacy violations than HIPAA-protected
health information.
Given the HIPAA Privacy Rule’s limitations, individuals’ health
predictions can easily land in the hands of third parties who may use
them to further their own economic agendas.175 Employers, lenders,
169
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life insurers, and others with a stake in individuals’ future wellbeing
may be interested in predictions about individuals’ future health
status.176 Employers for example, are interested in employees who
will not have productivity or absenteeism problems and will not
generate high health insurance costs.177 They may be very tempted
to reject or terminate workers who they believe to be at high risk of
becoming seriously ill in the coming years. Similarly, lenders seek
borrowers who will remain able to work and pay off their loans, and
life insurers may use predictive information about applicants to
make eligibility or pricing decisions.178
Currently, the anti-discrimination laws do not prohibit
employers and others from discriminating based on predictions of
future health problems (other than predictions based on genetic
information, which are covered by GINA).179 The Americans with
Disabilities Act (ADA), the primary federal disability
discrimination law, prohibits discrimination related only to:
(A) a physical or mental impairment that substantially
limits one or more major life activities of such
individual;
(B) a record of such an impairment; or
(C) being regarded as having such an impairment.180
Consequently, it does not reach discrimination based on future
physical or mental impairments or disabilities. This legislative gap
creates worrisome opportunities for discrimination based on disease
predictions.
Predictive health analytics may also perpetuate other types
of discrimination, such as sex or race-based discrimination.
Amazon’s effort to develop artificial intelligence-driven software to
identify the best job candidates illustrates the point.181 Because the
predictive model’s training data were past resumes submitted to
Amazon mostly by men, the program was biased against women and
176
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concluded men were preferable job candidates.182 It is just as likely
that predictive models in the healthcare arena will be biased and
wrongly conclude that women are at higher risk of various health
problems. Likewise, if companies such as LexisNexis and Acxiom
base predictive models on variables that include criminal records
and voter registration data,183 they could disproportionately identify
certain minorities as high-risk patients.
C. Erroneous Predictions
To make matters worse, the results of predictive health analytics
can often be wrong.184 In one illustrative example outside the health
field, scientists produced “fooling images” that were completely
unrecognizable to humans, but deep neural networks (a form of
machine learning) believed “with near certainty” that they were
familiar objects.185 Flawed outcomes can stem from a variety of
problems.
One reason can be human error in the algorithm or its
implementation. Big data used to train computers and develop
learning algorithms can be rife with inaccuracies and data gaps or
otherwise be a poor fit for the task at hand.186 Poor data quality will
inevitably lead to poor data-driven artificial intelligence algorithms,
consistent with the “garbage in-garbage out” principle.187
Even with a correct learning algorithm, the performance the
predictive model exhibits using the training data188 may not
182
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generalize to real world data because of a phenomenon called
“overfitting.”189
A particular model can produce accurate
predictions on a set of training data but fail to provide sound
predictions when deployed on new data, especially if the model is
complex and the training data set was small.190 Because of the
dearth of training data and the large number of parameters used to
construct the model, “the learned parameters are spuriously
inferred” and are unlikely to generalize well to unseen data.191 In
other words, overfitting occurs when a predictive model fits the
training data “too well.”192
Big data can also be subject to selection bias. If the data used to
train learning algorithms or statistical models comes from a health
system that serves particular populations (e.g. disproportionately
wealthy or disadvantaged individuals) but not others, the algorithm
or model may not be generalizable to all patients.193 Several
scholars have noted the following:
Big data has not captured certain marginalized demographics.
Particularly concerning are racial minorities, people with low
socioeconomic status, and immigrants. Many of the people
missing from the data that come from sources such as Internet
history, social media presence, and credit-card use are also
missing from other sources of Big Data, such as electronic health
records (EHRs) and genomic databases. The factors responsible
for these gaps are diverse and include lack of insurance and the
inability to access healthcare, to name just two….194
Unfortunately, it is often impossible to discern whether a
predictive model is sound. Learning algorithms are often opaque
because they rely on extremely complex rules and even their
programmers are uncertain about how they ultimately work.195
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Some commentators use the term “black box medicine” to describe
reliance on nontransparent learning algorithms.196
Use of the terms “artificial intelligence” and “machine learning”
can over-awe people. But as one commentator notes, “the only sure
prediction about the future of big data and predictive analytics is that
it is unlikely to live up to some of the hype.”197 Therefore,
algorithms, in many cases, will falsely predict that individuals will
suffer particular conditions in the future, and the affected data
subjects will be left to suffer the consequences.

V.

RECOMMENDATIONS

At its core, this Article is a call to action. The policy and
scientific communities must not ignore the potential risks of
predictive health analytics. Just as the growth of genetic testing
elicited robust academic and policy debates, so too should the
burgeoning phenomenon of predictive health analytics. Effective
legal and policy interventions are needed to safeguard the rights of
data subjects. This section recommends changes to the HIPAA
Privacy and Security Rules and to the Americans with Disabilities
Act. It also advocates for the implementation of other oversight and
self-regulation mechanisms.
A. Legal Interventions
Legislators should modify the laws that establish privacy and
anti-discrimination mandates. This section focuses on the federal
HIPAA Privacy and Security Rules and Americans with Disabilities
Act, though states could make similar changes to parallel state
laws.198 It also briefly examines whether the Food and Drug
Administration (FDA) could regulate learning algorithms used for
long-term predictive health analytics.
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1. The HIPAA Privacy and Security Rules
As I have argued in other work,199 Congress and the Department
of Health and Human Services should expand HIPAA’s definition
of “covered entity.”200 The need for change has become all the more
urgent in light of the growing use of predictive health analytics. The
federal law and regulations should adopt the language of a much
broader Texas privacy statute:
"Covered entity" means any person who:
(A) for commercial, financial, or professional gain,
monetary fees, or dues, or on a cooperative, nonprofit, or pro
bono basis, engages, in whole or in part, and with real or
constructive knowledge, in the practice of assembling,
collecting, analyzing, using, evaluating, storing, or transmitting
protected health information. The term includes a business
associate, health care payer, governmental unit, information or
computer management entity, school, health researcher, health
care facility, clinic, health care provider, or person who
maintains an Internet site;
(B) comes into possession of protected health information;
(C) obtains or stores protected health information under this
chapter; or
(D) is an employee, agent, or contractor of a person described
by Paragraph (A), (B), or (C) insofar as the employee, agent, or
contractor creates, receives, obtains, maintains, uses, or transmits
protected health information.201
This change would require a parallel modification to the
definition of “health information.”202 “Health Information” should
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be expanded to mean “any information, recorded in any form or
medium, that relates to the past, present, or future physical or mental
health or condition of an individual, including health predictions, the
provision of healthcare to an individual, or the past, present, or
future payment for the provision of healthcare to an individual.”203
Expanding the definitions of “covered entities” and “health
information” would not prevent healthcare providers from
contracting with business associates such as LexisNexis or Axciom
to conduct predictive health analytics so long as they did so for
purposes of treatment, payment, or health care operations.204 It also
would not prevent data brokers from accessing much of the data they
use, such as Facebook posts, shopper loyalty program records, or
voter registration data.205
Nevertheless, the change would provide patients with
several important benefits. First, it would prevent the newly covered
entities from disclosing health predictions to third parties without
the data subject’s consent. These predictions would constitute health
information about individuals’ future physical or mental health
conditions, and thus data brokers and other commercial enterprises
could not sell them without permission to marketers, employers, and
other interested parties for financial gain. Second, upon request, the
newly covered entities would be bound to inform data subjects of all
disclosures of their protected health information that were made.206
Third, the newly covered entities would have to comply with the
security mandates of the HIPAA Security Rule.207 They therefore
would be prohibited from storing health information and health
predictions about individuals with sloppy or minimal security
measures that do not adequately deter hacking.
In addition, the HIPAA Privacy and Security Rules should
include a private cause of action.208 Because of budgetary
or the past, present, or future payment for the provision of health care to
an individual.
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constraints, government enforcement is often anemic.209
Furthermore, it does not provide aggrieved parties with monetary
relief if they have suffered injury resulting from a privacy breach.210
The proposed HIPAA changes could meaningfully enhance data
subjects’ privacy protections and rights.
2. The Americans with Disabilities Act
I have also previously argued for a broadening of the Americans
with Disabilities Act’s (ADA) definition of “disability,” and I renew
my call for this change here.211 The ADA’s “regarded as” provision
protects only individuals who are “being regarded as [currently]
having … an impairment.”212 Congress should revise the “regarded
as” provision of the ADA to include individuals who “are perceived
as likely to develop physical or mental impairments in the future.”213
This change would prohibit employers and other parties from
discriminating against individuals because of disease predictions.214
It follows logically from GINA, which forbids discrimination based
on a specific type of predictive data - genetic information.215 In the
era of predictive health analytics, there is no justification for
retaining a discrepancy between GINA and the ADA. This is
particularly true because predictive models can forecast inherited
diseases such as heart conditions and some forms of Alzheimer’s
disease.216 Presumably, GINA would not cover such predictions
because they are not based on genetic tests or family histories.217
The law should not leave individuals who are identified as being at
risk for future diseases vulnerable to discrimination and protect
them only if the prediction is rooted directly in genetic information.
With respect to anti-discrimination mandates, genetic
exceptionalism218 no longer makes sense.
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3. FDA Regulation?
Genetic tests are subject to regulation by the FDA and the
Centers for Medicare and Medicaid Services (CMS), which
oversees clinical laboratories.219 CMS would not regulate learning
algorithms because no clinical laboratories are involved, and a real
question exists as to whether the FDA will routinely do so.
The FDA regulates medical devices, which are defined as any
“instrument, apparatus, implement, machine, contrivance, implant,
in vitro reagent, or other similar or related article which is intended
for use in the diagnosis of disease or other conditions, or in the cure,
mitigation, treatment, or prevention of disease, in man or other
animals.”220 Arguably, the FDA has authority to regulate learning
algorithms as contrivances that are used for the diagnosis and
prevention of disease.221 In early 2018 the FDA in fact approved an
algorithm.222 It provided premarket clearance for the WAVE
Clinical Platform, an early-warning system for hospitals that uses
vital sign data to identify patients at risk of becoming unstable.223
Even under this liberal interpretation, however, the agency is
empowered to regulate only algorithms used for medical care.224 It
would not have jurisdiction over predictive health analytics
conducted by marketers, employers, or other parties for nonmedical
purposes.225
Moreover, the FDA has traditionally refrained from regulating
the practice of medicine.226 Thus, it may hesitate to regulate learning
algorithms when their use seems akin to medical practice.227 While
WAVE may be classified as a device designed to predict imminent
medical crises,228 long-term predictive analytics are a poorer match.
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At best, they merely assist physicians in making decisions about a
patient’s future care.
Professor Nathan Cortez argues that predictive health analytics
do not fit comfortably into any of the familiar categories of medical
products, medical practice, or medical information for regulatory
purposes.229 He and others argue for a new regulatory paradigm.230
Resolving the controversy regarding FDA regulation of learning
algorithms is beyond the scope of this paper. Suffice it to say that
no governing authority regularly scrutinizes learning algorithms
before they are deployed in order to ensure their quality. Long-term
health predictions can significantly impact people’s lives. Much
more must be done to construct thoughtful, responsible legal
oversight mechanisms for predictive health analytics.

B. Other Oversight Mechanisms
Academics and other experts have begun building a literature
about the legal and ethical implications of predictive health analytics
only in recent years.231 It is a long way from reaching the
proportions of the genetic testing literature. Moreover, existing
literature has paid little attention to long-term predictive health
analytics, which raise unique concerns about psychological harms
and discrimination.232 Legal and bioethics scholars should no more
ignore these risks than they did the risks of genetic testing. What
follows is a brief discussion of potential oversight improvements for
the predictive health analytics industry and medical professionals.
1. Predictive Health Analytics Oversight
A few papers have undertaken the development of initial
guidelines for predictive health analytics.233 For example, a panel of
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seventeen experts proposed the following guiding principles in
2016:
1. Data Barriers: Establish mechanisms within the scientific
community to support data sharing for predictive model
development and testing.
2. Transparency: Set standards around e-HPA validation based
on principles of scientific transparency and reproducibility.
3. Ethics: Develop both individual-centered and societycentered risk-benefit approaches to evaluate e-HPA.
4. Regulation and Certification: Construct a self-regulation
and certification framework within e-HPA.
5. Education and Training: Make significant changes to
medical, nursing, and paraprofessional curricula by
including training for understanding, evaluating, and
utilizing predictive models.234
The scholars that have pondered predictive health analytics all
agree that transparency and oversight are of critical importance.235
They recommend the establishment of industry-wide validation and
certification mechanisms implemented by the Joint Commission,
certifiers overseen by the FDA, independent institutional review
boards, or other third parties.236
Experts have developed a variety of techniques to assess
learning algorithms and predictive models.237 A popular method for
estimating prediction error is cross-validation.238 Another method to
assess statistical accuracy is the bootstrap method.239 Most
importantly, researchers should validate learning algorithms in the
field, using real patients under the same conditions as those intended
for the algorithm’s post-approval use.240 Such validation should
ensure that the algorithm’s predictive capability generalizes to the
true target population.241 Oversight bodies should consist of
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predictive health analytics and validation experts who can be trusted
to scrutinize proposed assessment methods and ensure that they are
appropriate.242
The recommendations offered thus far are sound, and experts
should continue to develop and augment them in order to furnish
policy-makers with proposals that are as detailed and evidencebased as possible. Oversight and quality control could prevent many
erroneous predictions and save clinicians and patients considerable
angst.
2. Self-Regulation by the Medical Profession
Health care professionals would be wise to adopt their own
safeguards in order to minimize the hazards of long-term disease
predictions for patients. To that end, physicians should receive
training concerning long-term predictive health analytics so that
they understand the extent to which it can be limited and uncertain.
They should also counsel and educate patients before disclosing
troubling health predictions to them. A process akin to genetic
counseling would be very useful.243 Patients should understand the
advantages and disadvantages of learning about their disease risks
and be able to make informed decisions about their choice.
In addition, professional organizations should develop
practice guidelines regarding when it is appropriate to employ
predictive health analytics and the extent to which clinicians should
rely upon them.244 For example, practice guidelines might
recommend that clinicians refrain from obtaining certain types of
predictions about children.245 They might also suggest which
interventions should and should not be implemented in response to
predictions of suicidal ideation, clinical depression, opioid addiction
or other ailments. Education, counseling, and practice guidelines
could go far in maximizing the benefits and minimizing the risks of
predictive health analytics.
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IV.

CONCLUSION

We should not be blinded by enthusiasm for long-term
predictive health analytics or be naively seduced by technologies
with impressive names like artificial intelligence and machine
learning. Certainly, there is much to be gained from prudent use of
new predictive capabilities. However, the technologies come with
significant risks of psychological harm, privacy violations, and
discrimination, among others. Moreover, predictive models and
learning algorithms are often flawed and produce erroneous
outcomes. Many of these potential harms were previously
considered and addressed in the context of genetic testing.
Scientists and policy-makers would be wise to adopt similar
approaches for long-term predictive health analytics. This paper has
proposed just a few legal and non-legal interventions. These are
designed to enhance data subjects’ privacy rights, antidiscrimination protections, and ability to make informed decisions
about obtaining disease predictions. However, many more minds
must tackle the challenges of predictive health analytics and develop
mechanisms to enhance the integrity and benefits of these
technologies.
Ignoring the potential perils and unintended
consequences of long-term predictive analytics is imprudent and
could cost society dearly.

37

